← FDA Drug Approvals (Drugs@FDA)

IRBESARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2025-11-04

Drug application

FDA Application #

ANDA219539

Application type

Abbreviated New Drug Application (Generic)

Brand name

IRBESARTAN

Generic name

IRBESARTAN

Active ingredients

IRBESARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

Manufacturer

Novadoz Pharmaceuticals LLC

First approval

2025-11-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown